Skip to main content

Precision medicine

Whether you're bringing a precision medicine product to market or learning which treatment option is best for your patient, we can help you find answers.
  • Deploy personalized medicine strategies throughout development to increase your therapeutic candidate’s probability of success

  • Utilize biomarkers in preclinical and clinical development for key and timely insights to make more informed decisions

  • Co-develop your therapeutic candidate with a companion diagnostic to maximize uptake and competitive advantage


Cell & Gene Therapies

Preclinical capabilities 

Supported development of both FDA-approved CAR-Ts and the first FDA-approved gene replacement therapies

More than 20 years of experience delivering development solutions for advanced therapies


Translational Biomarker Solutions to guide your decision-making from discovery to the clinic

Biomarker Solution Center team of PhDs focused on key therapeutic areas, purpose of the biomarker, intended use and tools


Applied genomics expertise from single target to whole genome analysis, for both exploratory and regulated testing

Global co-location with the #1 provider of Central Labs, logistics and specimen management services


More than 30 different syngeneic tumor models, access to commercially generated humanized mouse models

Draw on over 1,000 immuno-oncology clinical study experiences in the last 10 years

Companion Diagnostics

Supported the development and/or commercialization of more than 60% of approved companion diagnostics

Supported the development of the first two FDA-approved complementary diagnostics

Co-development path enables reduced development time and costs

Advancing cancer care

Interested in next gen sequencing (NGS)?

Discover how we are using NGS to make a difference for cancer patients.